Publisher
Springer Berlin Heidelberg
Reference191 articles.
1. German Cancer Society, Head-Neck-Tumors, Treatment 2009 [Deutsche Krebsgesellschaft, Kopf-Hals-Tumoren, Therapie 2009]. (
www.krebsgesellschaft.de/pat_ka_kopf_hals_tumor_therapie,108203.html
).
2. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta- analysis of chemotherapy on head and neck Cancer. Lancet. 2000;355:949–55.
3. Taylor 4th SG, Murthy AK, Vannetzel JM, Colin P, Dray M, Caldarelli DD, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol. 1994;12:385–95.
4. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent post-operative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck. 2005;27:843–50.
5. Robbins KT. The evolving role of combined modality therapy in head and neck Cancer. Arch Otolaryngol Head Neck Surg. 2000;126:265–9.